@article{c5e62a8986f8419681e1e123576389dc,
title = "IQGAP1 restrains T-cell cosignaling mediated by OX40",
abstract = "A costimulatory signal from the tumor necrosis factor receptor (TNFR) family molecule OX40 (CD134), which is induced on activated T cells, is important for T-cell immunity. Aberrant OX40 cosignaling has been implicated in autoimmune and inflammatory disorders. However, the molecular mechanism by which the OX40 cosignaling regulates the T-cell response remains obscure. We found that OX40 associated with a scaffold protein, IQ motif-containing GTPase-activating protein 1 (IQGAP1) after ligation by its ligand OX40L. Na{\"i}ve CD4+ T cells from Iqgap1−/− mice displayed enhanced proliferation and cytokine secretion upon receiving OX40 cosignaling. A C-terminal IQGAP1 region was responsible for its association with OX40, and TNFR-associated factor 2 (TRAF2) bridged these two proteins. The enhanced cytokine response in Iqgap1−/− T cells was restored by the expression of the C-terminal IQGAP1. Thus, the IQGAP1 binding limits the OX40 cosignaling. Disease severity of experimental autoimmune encephalomyelitis (EAE) was significantly exacerbated in Iqgap1−/− mice as compared to wild-type mice. Additionally, recipient mice with Iqgap1−/− donor CD4+ T cells exhibited significantly higher EAE scores than those with their wild-type counterparts, and OX40 blockade led to a significant reduction in the EAE severity. Thus, our study defines an important component of the OX40 cosignaling that restricts inflammation driven by antigen-activated T cells.",
keywords = "CD4 T cells, T-cell inflammation, TNFRSF, autoimmunity, cosignaling",
author = "Yuko Okuyama and Hiroyuki Nagashima and Masuko Ushio-Fukai and Michael Croft and Naoto Ishii and Takanori So",
note = "Funding Information: We thank WF Bahou for mice. We thank members of Department of Microbiology and Immunology, Tohoku University Graduate School of Medicine for their assistance and help. We thank the Biomedical Research Core and the Institute for Animal Experimentation, Tohoku University Graduate School of Medicine, for technical support. This work was supported by JSPS KAKENHI grant numbers JP15K19123 (to YO), JP14J06157 (to HN), JP24590571 (to TS), JP15H04640 (to TS), JP18H02572 (to TS), JP24390118 (to NI), JP15H04742 (to NI), and the Takeda Scientific Foundation (to TS), the Suzuken Memorial Foundation (to TS), the SENSHIN Medical Research Foundation (to YO, TS), and the Daiichi‐Sankyo Foundation of Life Science (to TS, NI). Iqgap1 −/− Funding Information: We thank WF Bahou for Iqgap1?/? mice. We thank members of Department of Microbiology and Immunology, Tohoku University Graduate School of Medicine for their assistance and help. We thank the Biomedical Research Core and the Institute for Animal Experimentation, Tohoku University Graduate School of Medicine, for technical support. This work was supported by JSPS KAKENHI grant numbers JP15K19123 (to YO), JP14J06157 (to HN), JP24590571 (to TS), JP15H04640 (to TS), JP18H02572 (to TS), JP24390118 (to NI), JP15H04742 (to NI), and the Takeda Scientific Foundation (to TS), the Suzuken Memorial Foundation (to TS), the SENSHIN Medical Research Foundation (to YO, TS), and the Daiichi-Sankyo Foundation of Life Science (to TS, NI). Publisher Copyright: {\textcopyright} 2019 The Authors. The FASEB Journal published by Wiley Periodicals, Inc. on behalf of Federation of American Societies for Experimental Biology",
year = "2020",
month = jan,
day = "1",
doi = "10.1096/fj.201900879RR",
language = "English (US)",
volume = "34",
pages = "540--554",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "1",
}